Login / Signup

SARS-CoV-2 vaccination in patients with inflammatory bowel disease.

Ralley E PrenticeClarissa RentschAysha H Al-AniEva ZhangDouglas JohnsonJohn HallidayRobert V BryantJacob BegunMark G WardPeter J LewindonSusan J ConnorSimon GhalyBritt Christensen
Published in: GastroHep (2021)
SARS-CoV-2 vaccination is essential from both an individual patient and community perspective and should be encouraged in patients with IBD. Recommendations must be continually updated as real-world and trial-based evidence emerges.
Keyphrases
  • sars cov
  • patients with inflammatory bowel disease
  • respiratory syndrome coronavirus
  • healthcare
  • study protocol
  • clinical trial
  • case report
  • mental health
  • phase iii
  • phase ii
  • ulcerative colitis
  • open label